Cannabis, motivation, and life satisfaction in an internet sample by unknown
BioMed Central
Substance Abuse Treatment, 
Prevention, and Policy
ssOpen AcceResearch
Cannabis, motivation, and life satisfaction in an internet sample
Sara Smucker Barnwell*1, Mitch Earleywine2 and Rand Wilcox3
Address: 1University of Southern California, Department of Psychology, SGM 501, 3620McClintock Avenue, Los Angeles, CA 90089-1061, USA, 
2The University at Albany, SUNY, Department of Psychology, Social Sciences 369, 1400 Washington Avenue, Albany, NY 12222, USA and 
3University of Southern California, Department of Psychology, SGM 501, 3620McClintock Avenue, Los Angeles, CA 90089-1061, USA
Email: Sara Smucker Barnwell* - smucker@usc.edu; Mitch Earleywine - mearleywine@albany.edu; Rand Wilcox - rwilcox@almaak.usc.edu
* Corresponding author    
Abstract
Although little evidence supports cannabis-induced amotivational syndrome, sources continue to
assert that the drug saps motivation [1], which may guide current prohibitions. Few studies report
low motivation in chronic users; another reveals that they have higher subjective wellbeing. To
assess differences in motivation and subjective wellbeing, we used a large sample (N = 487) and
strict definitions of cannabis use (7 days/week) and abstinence (never). Standard statistical
techniques showed no differences. Robust statistical methods controlling for heteroscedasticity,
non-normality and extreme values found no differences in motivation but a small difference in
subjective wellbeing. Medical users of cannabis reporting health problems tended to account for a
significant portion of subjective wellbeing differences, suggesting that illness decreased wellbeing.
All p-values were above p = .05. Thus, daily use of cannabis does not impair motivation. Its impact
on subjective wellbeing is small and may actually reflect lower wellbeing due to medical symptoms
rather than actual consumption of the plant.
The link between cannabis use and low motivation is a
source of extensive debate. Anecdotal information
describes the cannabis user as listless and incapable. Sub-
sets of cannabis users demonstrating low motivation
receive considerable attention in the media and among
proponents of marijuana prohibition. Decades ago,
researchers adopted the phrase "amotivational" to
describe lethargic cannabis users. Amotivational syn-
drome ranks among key problems associated with the
drug, and strengthens policy arguments regarding the
public harm that the drug introduces [1]. The US Depart-
ment of Health and Human Services [1] warns parents
that youth cannabis use may result in amotivational
symptoms such as an apathetic approach to life, fatigue,
and poor academic and work performance. Other studies
suggest that cannabis induces general apathy and an ina-
bility to progress through life successfully [2]. Yet empiri-
cal research on the effects of cannabis on users'
motivation suggests a low incidence of these negative out-
comes and numerous alternative explanations for their
appearance [3-5].
A review of the laboratory performance research, educa-
tion data and employment statistics demonstrate little
support for symptoms associated with amotivational syn-
drome. Research on the most straightforward constructs
associated with motivation (e.g. goals, focus and general
productivity) fail to offer consistent evidence linking can-
nabis to any deficits. Some studies connect low focus and
lack of goals among users with repeated cannabis use, cit-
ing possible neurological causes [2,6]. Others show that
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ductivity and clarity in work tasks [7].
Investigations of other indices, including employment
and education, also offer little support for amotivation.
Cannabis use appears orthogonal to wages or job turno-
ver. An examination of over 8000 people suggests that
some frequent cannabis users earn higher wages than
abstainers [8]. Compared to non-smokers, marijuana
smokers are no more likely to be fired from their jobs
[9,10]. Educational outcomes vary among frequent can-
nabis users. High school students using cannabis are
likely to have lower grades than non-users [11], but often
report using other substances that may affect grades [e.g.
alcohol, other illicit drugs; [12]]. Most heavy users earned
lower grades prior to their marijuana consumption, sug-
gesting cannabis could not have caused the poorer per-
formance [13]. College students who smoke cannabis
demonstrate comparable [14] or even higher [15,16]
grades than their cannabis abstinent classmates, and are
more likely to pursue a graduate degree [14].
While most cannabis users do not suffer observable prob-
lems with motivation, a subset of heavy, chronic users
believe that the plant impairs their drive. In several studies
heavy cannabis users report that marijuana affected their
motivation [17,18]. However, it is notable that other var-
iables (e.g. comorbid drug use, baselines for low motiva-
tion) may not be examined. Long-term chronic cannabis
users may demonstrate hazardous drinking behaviors
[19,18]. Reilly, Didcott, Swift and Hall [18] found that
perceived cannabis effects outweighed perceived effects of
alcohol, a drug commonly associated with numerous neg-
ative consequences [e.g. [20]]. Moreover, many people
demonstrate low motivation regardless of drug use. Dun-
can [21] found that 5% of over 200 students demon-
strated amotivational symptoms regardless of substance
use. It is possible that marijuana smokers misattribute low
motivation symptoms to the plant [3].
Furthermore, not all chronic cannabis users reporting low
motivation encounter the experience as negative. Com-
pared to occasional smokers, heavy smokers in one study
reported lower motivation but also higher levels of life
satisfaction [17] – a primary component of subjective
wellbeing [22] This result might suggest that users have
different goals, but cannabis users do not have a passive
and non-materialistic view of achievement compared
with nonusers [23]. Thus cannabis users do not necessar-
ily eschew traditional hallmarks of success. Yet if some
heavy cannabis users derive life satisfaction outside of
these motivated, culturally normative routes, then how
may we understand their behaviors? Earleywine [3] pon-
ders whether chronic users reject conventional associa-
tions among motivation, productivity and life
satisfaction, and ascribe to a subculture of different values.
The extant literature addressing cannabis use, motivation
and life satisfaction possess myriad problems inherent to
research of this nature. Given the illegality of cannabis
use, variable definitions of heavy use and abstinence, as
well as problems studying individuals who lack motiva-
tion, research on cannabis and motivation proves chal-
lenging. Potential participants may hesitate to admit
illegal activity. As a result, many studies on amotivational
syndrome among cannabis users employ small samples
[e.g. N = 5; [24]]. With smaller sample sizes, further sub-
division into groups of chronic users and non-users
diminishes statistical power and potential findings.
Further, researchers may define frequent cannabis use in a
number of ways. Some studies may define heavy cannabis
users as those who use the drug daily [e.g. [17]], while oth-
ers define heavy use as twice or more per week [e.g. [23]].
Similarly, studies may define cannabis abstinence differ-
ently. One study defines abstainers as those who have not
used the drug more than ten times [17]; another defines
abstainers as those who have never used the drug [e.g.
[25]], and numerous others rely on survey items that sim-
ply ask whether the subject currently uses cannabis. These
methodological issues surrounding cannabis research
(e.g. small sample size, inconsistent definition of heavy
use vs. abstinence) pose possible barriers to findings. Few
studies employ robust statistical methods to capture
potentially small differences. Further, laboratory studies
may lose potential subjects whose low motivation pre-
vents them from traveling to the laboratory. Because of
these possible confounds, supporters of amotivational
syndrome argue that research finding no link between
cannabis and motivation overlooks potential effects.
Despite the dearth of research supporting a link between
cannabis use and low motivation, the notion persists in
popular culture and academia. In the public eye, the
minority of heavy cannabis users who show low motiva-
tion represents the majority. This misrepresentation intro-
duces possible impediments to the effective treatment of
cannabis abuse and dependence. We address the popular
myth of the association between heavy cannabis use and
low motivation in a large internet sample. The study
examines self-reports of motivation among daily cannabis
users and lifetime cannabis abstainers. We further seek to
gauge the life satisfaction or subjective wellbeing among
daily users compared to abstainers.
This study overcomes numerous methodological prob-
lems by employing a large internet sample, strict defini-
tions of use and abstinence and robust statistical analyses.
The large sample with sizeable subgroups provides ade-Page 2 of 9
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strict definitions of chronic cannabis use (as daily use)
and abstinence (as never trying the drug) should maxi-
mize group differences. Gathering data on the internet
also serves as a potential strength. Participation does not
require enough motivation to travel to a laboratory.
Finally, in addition to standard statistical analyses,
advanced, robust measures of inter-group differences fur-
ther improve statistical power.
Method
Procedure
Participants responded to an email request to complete an
Internet survey on cannabis use and attitudes. An initial
email was sent to 200 undergraduates who had taken a
course on drugs and human behavior and 100 acquaint-
ances of the second author. The email requested that they
complete the questionnaire and forward the request to
others. Respondents forward the email, and approxi-
mately 1300 people replied from a variety of back-
grounds, as described below.
Measures of cannabis consumption
Participants responded to several questions regarding
their cannabis consumption. An Internet consent proto-
col ensured confidentiality of all responses. Respondents
first answered whether or not they had ever tried canna-
bis. Those who indicated "No" comprise the non-user
group (N = 244). The remaining respondents answered
questions regarding the frequency of their cannabis con-
sumption. Those who indicated using cannabis seven
days a week comprise the frequent cannabis user group (N
= 243). The amount of cannabis consumed at one time
varies considerably. However, limiting the user group to
those who use the drug seven days per week should ensure
that these individuals are regular users. Among frequent
cannabis users, the median number of lifetime uses of the
drug was 3000 times. The study, however, focuses on
users' reports of current use to avoid hindsight bias in
reporting and parallel questions on current motivation
and subjective wellbeing. Almost one third (31%) of users
considered themselves medical cannabis users, citing
chronic pain, nausea and other medical concerns as rea-
sons for using the drug. Whereas these individuals consti-
tute a small but not insignificant portion of chronic
cannabis users (e.g. 15% of the present sample) and their
reports of health problems may only increase the likeli-
hood of encountering differences between users and
abstainers, the present study includes these individuals in
analyses.
Motivation
Respondents completed items from the Apathy Evalua-
tion Scale [AES; [26]]. Participants responded to 12 state-
ments regarding their own feelings of motivation on a
four-point scale (e.g. Not At All; Slightly; Somewhat; Very
Much). Eight items that accounted for the most variance
in the scale according to scale reliability analyses were
selected. Additional items were added based on face valid-
ity. See Table 2. The twelve items possessed sound internal
consistency (Cronbach's α = .82). Similar measures of
apathy have been used successfully in previous studies of
substance use and motivation, showing increased apathy
among the cocaine dependent [27]. See Table 2 for a com-
plete list of items. Preliminary data analyses for this study
indicated that higher internal consistency (Cronbach's α =
Table 1: Demographic Differences Among Daily Cannabis Users and Lifetime Abstainers
Daily Cannabis Users Cannabis Non-Users
Sample Size (N) 243 244
Gender 81% male; 19% female 51% male; 49% female
Average Age* M = 37.8, SD = 13.3 M = 28.2, SD = 11.0
Maximum Income Bracket** M = $44,431, SD = $23,027 M = $39,640, SD = $24,159
*Significant age differences emerged, t(473) = -8.56, p < .001.
**Significant income differences emerged, t(406) = -2.04, p < .05
Table 2: Apathy Evaluation Scale Items
I get things done during the day Getting things done during the day is important to me
I approach life with intensity Seeing a job through to the end is important to me
Getting things done on my own is important to me I have initiative*
I have motivation* I set goals for myself
I don't follow through on my plans (reverse coded)* I have some interesting projects I'm working on
I'm pretty productive most of the time* I am interested in things
*Items selected for face validity. Item total correlations range from .30 to .73.Page 3 of 9
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through on my plans) was removed. Internal consistency
would not increase with the deletion of any other items.
Thus the most reliable items measuring motivation sum
to provide a composite 44-point motivation scale.
Subjective well-being
Respondents completed the Satisfaction with Life Scale
[22]. The measure has been validated extensively, show-
ing good reliability and convergent validity [28]. The
measure includes five statements about the subject's qual-
ity of life (See Table 3). Respondents rated each statement
on a seven-point scale (e.g. Strongly Disagree; Disagree;
Slightly Disagree; Neither Agree nor Disagree; Slightly
Agree; Agree; Strongly Agree). The removal of one item
("If I could live my life over, I would change almost noth-
ing") increased internal consistency (α = .87) derived via
item reliability analyses. Internal consistency would not
increase with the deletion of any other items. Thus final
measures of subjective well-being were derived from four
of the five items.
Robust statistical methods
Throughout the analyses, we sought to apply the best sta-
tistical techniques available. Whereas many of our analy-
ses required means comparisons, we examined problems
associated with typical tests of mean difference (e.g. T-
tests). Under unequal variances or heteroscedasticity, Stu-
dent's T-distribution may mask true differences even as
the sample size increases [29,30]. Whereas outliers may
inflate sample variances, a straightforward comparison of
sample variances often does not sufficiently identify het-
eroscedasticity. Given the potential for heteroscedasticity
and a large sample size, it is prudent to apply a method
that controls for unequal variances. Welch [31] devised a
comparison of means that provides accurate probability
coverage and improves statistical power under conditions
of heteroscedasticity.
While heteroscedastic means analysis control for unequal
variances, it does not consistently control outliers. Sample
means may be susceptible to inflation due to outliers [30].
Plots of motivation scores revealed outliers (e.g. data
points above/below three standard deviations) even after
standard data transformations (e.g. square roots). Even
standard transformations of the data (e.g. square roots)
may not control inflation of the mean due to outlying val-
ues. An alternative measure of location is the sample
median. By effectively removing 50% of the data from
each tail of the distribution, the sample median demon-
strates greater resistance to inflation due to outliers and
heteroscedasticity [30]. Thus the median may provide a
more accurate estimation of central tendency, and a com-
parison of medians may offer increased statistical power.
The present study employs median comparisons as an
alternative way to examine central tendency.
However, other methods offer sound alternatives to over-
coming outliers within the data. Wilcox [30] discusses the
merits of employing a comparison of trimmed means
among samples with numerous outliers. The trimmed
mean refers to a sample wherein a percentage of the larg-
est and smallest observations are removed, and the
remaining values are averaged. Just as the median may
offer a superior perspective by effectively removing 50%
of the data from each end of the distribution, lower
degrees of trimming may reveal more accurate estimates
of central tendency. Trimming 20% offers numerous
advantages over no trimming or the use of medians,
including a smaller standard error [30]. In this case, trim-
ming 20% of extreme values removes all outliers, leaving
a relatively normally distributed sample in tact. Yuen [32]
derived a method of comparing trimmed means, while
employing Welch's principles for heteroscedastic means
comparison. This approach can improve statistical power
markedly. Thus the present study also employs compari-
sons of trimmed means.
Finally, the present study employs alternative measures of
effect size. Effect size represents the estimated measure of
the degree of separation between two distributions. Effect
size estimates may further illustrate the magnitude of the
difference between groups. Cohen's delta (d) effectively
measures the separation of two distributions means, com-
paring them to a measure of standard deviation pooled
between both groups. Cohen's d calculations are highly
susceptible to problems associated with heteroscedasticity
and non-normality – the same problems associated with
standard means comparison [30]. McGraw and Wong
[32] describe an alternate measure of effect size based on
the probability of correctly deciding the group of origin of
any randomly sampled value. The resulting value, Q, indi-
cates the separation of the distributions and strength of
the effect.
Table 3: Subjective Well-being Scale Items
The conditions of my life are excellent In most ways, my life is close to ideal
I am satisfied with life So far I have gotten the important things that I want in life
If I could live my life over, I would change almost nothing
Item total correlations range from .57 to .79.Page 4 of 9
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Participants
Participant ages ranged from 18 to 81 (mean = 33.1, SD =
13.1). The group was primarily Caucasian (79%), with
Asian (8%), Latino (6%), mixed-race (2%), and African-
descent (2%) far behind. Over three quarters (77%) were
U.S. residents from a wide array of states, while the rest
were from Canada (17%), South Africa (1%), the United
Kingdom (1%) and other countries throughout Europe
and the Middle East (4%). Respondents varied in educa-
tion (18% reported some high school education or com-
pletion of high school, 31% attended some college; 26%
were college graduates; 7% had some graduate training,
and 19% held advanced degrees). We focus on two
extreme sub-samples, daily cannabis users (who smoked
7 days per week) and lifetime abstainers. Cannabis users
tended to be male, while gender was equally distributed
among abstainers. Cannabis users were significantly
older, and earned more money in their work. Other indi-
ces of achievement (e.g. grades) were not assessed. It is
notable that the preponderance of students with no
income in this sample renders findings regarding income
relatively difficult to interpret accurately. See Table 1 for
demographics of the two groups.
Motivation and Subjective Well-being. We employed
Pearson's correlations to examine relationship among
motivation and subjective well-being. Mean motivation
and subjective well-being scores correlated significantly in
the entire sample (r = .40, p < .001), among chronic can-
nabis users (r = .35, p < .001), and cannabis abstainers (r
= .462, p < .01). Age did not correlate significantly with
subjective well-being scores (r = .008, p > .05) or motiva-
tion scores (r = .08, p > .05).
Motivation in users vs. non-users
In general, subjects appeared relatively motivated (M =
38; SD = 5.6). A comparison of independent means
among subjects using cannabis seven days a week (M =
38.1; SD = 5.1) and non-users (M = 37.7; SD = 6.1)
revealed little difference (t(453) = .73, p = .47). Missing
data accounted for variation in degrees of freedom
throughout analyses. We avoided using covariates or
matching in initial analyses to provide maximum power
for detecting group differences. A plot of the data revealed
several outliers in each group. Square root transforma-
tions improved the skew, but revealed no significant dif-
ferences (t(453) = .50, p = .62).
The null results from standard statistical procedures led us
to turn to alternative techniques with better power.
Welch's heteroscedastic means comparison revealed little
difference among motivation scores for frequent cannabis
users and non-users (W(412) = .72, p = .47). Plots of moti-
vation scores revealed outliers even after standard data
transformations (e.g. square roots). A comparison of
median motivation among the cannabis users (Md = 39)
and non-users (Md = 39) again revealed no significant dif-
ference (p = 1 confidence interval: -0.85, 0.85). Using
Yuen's [32] method, a comparison of 20% trimmed
means among cannabis users (Mt = 38.8) and non-users
(Mt = 39.0) revealed no significant differences (Y(272) =
Motivation Scores Means, Medians and Trimmed Means ComparisonsFigure 1
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power failed to find differences in motivation between
daily users and non-users. Measures of effect size for moti-
vation using Cohen's d revealed a weak association (d =
.06). A Q value of .5 suggests no real effect. As with
Cohen's d, the robust analyses similarly found no signifi-
cant separation of the distributions – a very weak effect [Q
= .54; [30]]. See Figure 1.
Subjective well-being in users Vs. non-users
The most reliable items measuring subjective wellbeing
combine to form a composite 28-point scale. In general,
subjects reported high levels of subjective wellbeing (M =
20.9; SD = 4.9). A comparison of independent means
between daily users (M = 20.9; SD = 4.9) and non-users
(M = 21.3; SD = 4.9) revealed no significant difference
(t(426) = 1.3, p = .94). Again, we avoided using covariates
or matching procedures to ensure maximum power in the
detection of group differences. Measures of effect size sug-
gested a weak association (d = .1). A plot of the data
revealed several outliers in each group. Square root trans-
formations improved skew [33]. A comparison of the
mean square roots among the cannabis users and non-
users again demonstrated no differences (t(426) = 1.2, p
=.23).
A Welch's [31] comparison of heteroscedastic means
revealed no significant differences (W(405) = 1.3, p =.20).
Yuen's [32] comparison of 20% trimmed means among
frequent cannabis users and non-users revealed no signif-
icant differences in subjective well-being scores, but did
approach significance (Y(232) = 1.9, p = .05). Compari-
sons of medians between daily users (Md = 21) and non-
users (Md = 23), however, did reveal a small but statisti-
cally significant difference (p < .001; .95 confidence inter-
val: 1.46, 2.54). Thus, trimming 20% of the values failed
to reveal inter-group differences, but effectively removing
50% of the data from each end of the distribution resulted
in a significant finding.
Statistical power, the likelihood of finding a meaningful
effect between two distributions, increases as sample size
increase. Given a large enough sample size, many small
variations among groups may achieve statistical signifi-
cance. Given this study's large sample size (N = 487), we
employed further analyses to understand this statistically
significant finding in an appropriate context. Cohen's d
suggested a weak association between the variables. Simi-
larly, a robust measure of effect size found little effect [Q
= .55; [30]]. Thus while median differences among distri-
butions are statistically significant, the two point differ-
ence may have little clinical significance. See Figure 2.
Medical conditions as a source of decreased subjective 
wellbeing
Approximately one-third of frequent cannabis users were
medical users, who often report high levels of pain, nau-
sea and physical problems. To eliminate any possible con-
founds that these known medical problems could pose on
measurements of subjective wellbeing, we compared non-
medical cannabis users (N = 168, M = 21.2) with cannabis
abstainers (N = 244; M = 21.2). A standard comparison of
independent means revealed no differences (t(353) = .18,
p = .86). Similarly, comparisons of heteroscedastic means
revealed no significant differences in subjective well-being
scores (W(353) = .18, p = .86). Frequent users (Mt = 21.7)
Subjective Well-being Scores Means, Medians and Trimmed Means ComparisonsFigure 2
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cant differences with 20% trimmed means (Y(213) = 1.1,
p = .29). A comparison of medians among frequent can-
nabis users (Md = 22) and abstainers (Md = 23) revealed
a 1-point difference (p < .05, .95 confidence interval: 0.15,
1.85) on the 28-point scale. Again, Cohen's d suggested
little association between the variables. A robust measure
of effect size found little effect [Q = .51; [30]].
Discussion
In this study, participants who used cannabis seven days a
week demonstrated no difference from non-cannabis
users on indices of motivation. These findings refute
hypothesized associations between heavy cannabis use
and low motivation. Means and median comparisons,
data transformations, and robust comparisons of central
locations each revealed no statistically significant differ-
ences among motivation scores despite improvements in
power. Daily users reported slightly lower median subjec-
tive well-being scores (2 points less on a 28-point scale).
An examination of non-medical cannabis users' and
abstainers' subjective wellbeing scores revealed no mean
differences using standard or robust methods, but did
reveal a difference in median scores (1 point on a 28-point
scale). While cannabis users were older than abstainers,
age demonstrated no correlation with subjective wellbe-
ing and a very weak correlation with motivation. The dif-
ference in age between groups actually should increase the
likelihood of finding differences. For this sample size, an
effect size of d = .25 should be detectable with a power of
.80 and two-tailed alpha of .05. Effect size estimates using
Cohen's d ranged from .06 to .1. Robust measures of effect
size similarly reported no meaningful separation of distri-
butions.
These findings suggest that chronic cannabis users need
not develop motivation problems, but they report statisti-
cally significant, though small, decreases in subjective
wellbeing. Post-hoc tests find that some portion of the dif-
ferences in subjective wellbeing arose from medical users,
whose illnesses may contribute to low subjective wellbe-
ing more than their cannabis use. Whereas statistical
power grows as sample size increases, the study's large
sample size may lend statistical significance to findings
that have little practical meaning to the clinician (e.g. 1 or
2 points on a 28-point scale). Nevertheless, these results
do confirm the superior power of robust statistics and
should encourage investigators to turn to them as superior
to standard comparisons based on means. It is notable
that we did not employ covariates at any point through-
out the analyses (e.g. age, medical use). Researchers gen-
erally include covariates in an effort to ensure that a large
effect does not arise from differences between groups on
dimple demographic correlates of the dependent variable.
Our analyses demonstrated no effect. Thus the inclusion
of covariates would render group differences even smaller.
Analyses of the data examining suppressor effects con-
firmed that the inclusion of age and gender as covariates
would not reveal hidden effects
The relatively homogenous convenience sample used in
this study warrants a brief caveat. Overall, the sample was
largely Caucasian and educated. Further research on links
between cannabis and motivation among a more ethni-
cally diverse group from varying levels of education could
reveal different findings. Among daily smokers, the sam-
ple was largely male. While some studies suggest that
female chronic cannabis users closely resemble their male
counterparts [see [34]], a greater number of female sub-
jects could offer a more complete understanding of fre-
quent cannabis users. Still, many laboratory-based studies
on cannabis have similarly yielded largely male samples
[see [35,36]], and have offered valuable information to
the understanding of cannabis use.
Given the online format, the present study did not screen
participants for cannabis use or any other type of heavy
drug use. Furthermore, the present study did not exclude
individuals using other substances. Although the study
does focus expressly only cannabis use, previous research
does suggest that cannabis users may misattribute low
motivation to cannabis over other substances used
comorbidly [e.g. alcohol; [18]]. It seems likely that indi-
viduals who have abstained from lifetime use of cannabis
do not engage in use of other illicit substances. Still, the
study fails to find significant differences among the two
groups. Failure to control for comorbid drug use, while an
important limitation, would likely contribute to inter-
group differences among substance users and abstainers.
Thus we believe that this limitation does not limit inter-
pretation of the data. Even with users of other drugs
included among the cannabis users, they still report moti-
vation and well-being comparable to non-users.
Participant reactivity to questions of motivation may pose
an additional confound. Despite a lack of empirical evi-
dence supporting amotivational syndrome, the popular
concept is well known among cannabis users. Perhaps
cannabis users demonstrate sensitivity to questions
regarding motivation, exaggerating their own motivation
in an effort to defy stereotypes. In contrast, users tend to
attribute low energy and motivation to cannabis even
when they use alcohol problematically, so there may also
be a bias for cannabis users to report lower motivation
[18]. Further, collecting data via the internet may prevent
some low education or low income individuals from par-
ticipating. Others may feel uncomfortable reporting drug
use online. Simultaneously, individuals experiencing low
motivation may be more likely to participate in internet-
based research rather than traveling to a laboratory.Page 7 of 9
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ies that cite a lack of evidence for amotivational syndrome
[e.g. [37]]. The majority of chronic cannabis users in the
present sample report relatively high levels of motivation
comparable to their non-using counterparts. These find-
ings further suggest that cannabis abstainers report
slightly higher median levels of subjective wellbeing.
However, medical cannabis users with health problems
appear to account for a substantial part of this finding.
Standard and robust measures of effect size suggest little
association between cannabis use and motivation or can-
nabis use and subjective wellbeing. Thus these findings
merit further study.
A null association among frequent cannabis use and moti-
vation contradicts prevailing popular notions. In addition
to clarifying the effect of cannabis on the majority of its
users, the present findings offer implications for the treat-
ment of cannabis abuse and dependence. Debunking the
myth of amotivation among all chronic cannabis users
may prevent inappropriate treatments for all cannabis
abusing and dependent individuals. Some problem users
may be lulled into a false sense of security because they
still feel motivated despite cannabis-related life problems.
Researchers and clinicians may focus treatment on other
constructs possibly affecting motivation among chronic
cannabis users [e.g. peer group association; [37]; depres-
sion; 5]. Refuting an overarching connection between
chronic cannabis use and life satisfaction promotes
understanding of the severity and suffering of cannabis
dependent individuals seeking treatment. Further
research may also help to understand the experiences of
medical cannabis users, and the effect that cannabis has in
diminishing or promoting subjective wellbeing. By iden-
tifying and treating true etiological pathways underlying
substance abuse and its related social problems, scientists,
social policy and the public alike may adopt a more accu-
rate and compassionate understanding of the actual lives
and logic of the people in need of their help.
The absence of any link between motivation and cannabis
use also has important implications for preventing sub-
stance abuse. Research informs parents and children that
cannabis saps motivation [1]. It is possible that individu-
als' own experiences and the experiences of users they
know may belie this information, leading them to ques-
tion the veracity of other material presented in these pro-
grams. Thus, emphasizing a cannabis-induced
amotivational syndrome in drug prevention does not
have empirical support and could harm the credibility of
our efforts at prevention. Honest information about the
negative consequences of cannabis has the potential to
improve the prevention of drug problems. Dropping ref-
erences to amotivational syndrome may have considera-
ble benefit.
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